-+ 0.00%
-+ 0.00%
-+ 0.00%

Abvc Biopharma Says Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon; Reports Material Weakness In Internal Controls Over Financial Reporting For FY25

Benzinga·03/03/2026 21:54:39
Listen to the news

- SEC Filing